New concepts of hormonal therapyMaximal androgen blockadeIntermittent androgen suppressionAndrogen ablative therapy was introduced in the early 1940s and, even today, has remained the golden standard for the treatment of advanced prostate cancer. During the past decades, a variety of improvements have ...
Late radiotherapy toxicity after prostate cancer treatment: Influence of hormonal therapy Gratzle J: Late radiotherapy toxicity after prostate cancer treatment: influence of hormonal therapy - AB () Citation Context ...se of anticoagulants could... AB Jani,J Gratzle - 《Urology》 被引量: 46发表...
The D'Amico risk group classification was originally developed to estimate the risk of biochemical recurrence following treatment for localized prostate ca... SA Boorjian,RJ Karnes,LJ Rangel,... - 《Journal of Urology》 被引量: 450发表: 2008年 Outcome of prostate cancer patients with initial ...
Today, important controversies concerning the selection of the best primary treatment and the timing of initiating the hormonal therapy still exist. Second line hormonal strategies are used, but they still have to prove their impact on overall survival. 展开 关键词: Keywords Hormonal treatment ...
Hormonal therapy is the main treatment for men with disseminated prostate cancer. [1] In addition, hormonal therapy, also known as endocrine- or androgen-deprivation therapy, is commonly used in locally advanced or high-grade, high-risk disease. (See the image below.) Pathology of Hormonal ...
Androgen-deprivation therapy, the mainstay of treatment for advanced prostate cancer, incr... MR Smith - 《Clinical Genitourinary Cancer》 被引量: 86发表: 2008年 Bifurcation analysis on a hybrid systems model of intermittent hormonal therapy for prostate cancer Hybrid systems are widely used to ...
New Treatment Options for Patients With Metastatic Prostate Cancer: What Is The Optimal Sequence? Systemic treatment of men with metastatic prostate cancer is rapidly evolving. Androgen deprivation therapy remains the first-line treatment for advanced d... Joyce,M.,van,... - 《Clinical Genitourinary...
Intermittent hormonal therapy (IHT) for prostate cancer aims to minimize treatment-related side-effects, to improve overall quality of life, to reduce the cost of care, and possibly to delay progression to castration-resistant prostate cancer. With preclinical evidence suggesting a potential benefit fo...
RR Salloch,F Neumann,M Kramer - 《International Symposium on the Treatment of Carcinoma of the Prostate Berlin》 被引量: 0发表: 1971年 Hormonal treatment of cancer; Current status and perspectives The influence of the antiandrogen cypoterone acetate on the regulatory mechanisms of the hypophyseal...
Patients with high-risk prostate cancer are at an increased risk of biochemical recurrence, metastatic progression and cancer-related death following primary treatment compared with patients with low-risk or intermediate-risk disease. Multiple studies on neoadjuvant treatment using conventional androgen depriv...